Altered adhesion properties and alpha V integrin expression in a cisplatin-resistant human ovarian carcinoma cell line

被引:48
作者
Maubant, S
Cruet-Hennequart, S
Poulain, L
Carreiras, F
Sichel, F
Luis, J
Staedel, C
Gauduchon, P
机构
[1] Univ Caen, Ctr Francois Baclesse, Expt Cancerol Lab, Grp Reg Etud Canc, F-14076 Caen 05, France
[2] UFR Sci & Tech, Dept Biol, Grp Biol Cellulaire, ERRMECe, Cergy Pontoise, France
[3] Fac Pharm Marseille, CNRS, UMR 6032, F-13385 Marseille, France
关键词
integrins; chemoresistance; ovarian carcinoma;
D O I
10.1002/ijc.1600
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In order to elucidate the mechanisms underlying the development of chemoresistance in ovarian cancer, we have previously established the IGROV1-R10 cisplatin-resistant cell line by mimicking a clinical protocol of drug administration on IGROV1 human ovarian carcinoma cells. Both IGROV1 and IGROV1-R10 cells were able to grow as a monolayer and to release cell clusters into the medium. However, IGROV1-R10 cells exhibited an enhanced capacity to detach from the monolayer as compared to the parental cells. When substrate adhesion was prevented, IGROV1-R10 cells were able to survive and to proliferate as cell clusters, even at a low cell density, whereas IGROV1 cells massively died. To explore the underlying mechanisms, we have been interested in a-v integrins, which have been implicated in some aspects of ovarian cancer biology. Both IGROV1 and IGROV1-R10 adherent cells expressed alphav beta3 integrin. During cell growth, alphav beta5 integrin accumulated at the surface of a majority of IGROV1-R10 cells from the monolayer, whereas only a faint expression of this integrin was observed in a minority of IGROV1 cells. The growth of IGROV1-R10 cells, but not of IGROV1 cells, was partly inhibited by a specific alphav beta5-blocking antibody suggesting that alphav beta5 integrin contributed to IGROV1-R10 cell proliferation. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:186 / 194
页数:9
相关论文
共 40 条
[1]  
Auersperg N, 1998, SEMIN ONCOL, V25, P281
[2]  
BARTOLAZZI A, 1993, ANTICANCER RES, V13, P1
[3]  
BENARD J, 1985, CANCER RES, V45, P4970
[4]   POLARIZATION OF THE ALPHA-6-BETA-4 INTEGRIN IN OVARIAN CARCINOMAS [J].
BOTTINI, C ;
MIOTTI, S ;
FIORUCCI, S ;
FACHERIS, P ;
MENARD, S ;
COLNAGHI, MI .
INTERNATIONAL JOURNAL OF CANCER, 1993, 54 (02) :261-267
[5]   Focal adhesions, contractility, and signaling [J].
Burridge, K ;
ChrzanowskaWodnicka, M .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1996, 12 :463-518
[6]   EXPRESSION AND FUNCTION OF BETA-1 AND ALPHA-V-BETA-3 INTEGRINS IN OVARIAN-CANCER [J].
CANNISTRA, SA ;
OTTENSMEIER, C ;
NILOFF, J ;
ORTA, B ;
DICARLO, J .
GYNECOLOGIC ONCOLOGY, 1995, 58 (02) :216-225
[7]   Expression and localization of alpha v integrins and their ligand vitronectin in normal ovarian epithelium and in ovarian carcinoma [J].
Carreiras, F ;
Denoux, Y ;
Staedel, C ;
Lehmann, M ;
Sichel, F ;
Gauduchon, P .
GYNECOLOGIC ONCOLOGY, 1996, 62 (02) :260-267
[8]   IMPLICATION OF THE ALPHA-V-BETA-3 INTEGRIN IN THE ADHESION OF THE OVARIAN-ADENOCARCINOMA CELL-LINE IGROV1 [J].
CARREIRAS, F ;
LEHMANN, M ;
SICHEL, F ;
MARVALDI, J ;
GAUDUCHON, P ;
LETALAER, JY .
INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (04) :530-536
[9]  
Carreiras F, 1999, INT J CANCER, V80, P285
[10]   Human ovarian adenocarcinoma cells synthesize vitronectin and use it to organize their adhesion [J].
Carreiras, F ;
Cruet, S ;
Staedel, C ;
Sichel, F ;
Gauduchon, P .
GYNECOLOGIC ONCOLOGY, 1999, 72 (03) :312-322